Fuse Vectors

Cell & Gene Therapy

Facts

as of Nov 19, 2026

Top of page Our Story Fuse Vectors was born from a shared vision to build better viral vectors for gene therapy. Drawing on their industry experience, Benjamin and Jordan took a bold leap to rethink how AAVs are made, and along the way, they were joined by Henrik, to help bring the vision to life.

Employees
11-50estimated range

These are the key facts about Fuse Vectors on Alion as of Nov 19, 2026. The latest round is Pre-Seed of $5.2M, announced in 2025.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Financials

Funding rounds, investors and revenue on record.

$5.2MTotal raised
Pre-SeedLatest round
1Rounds and grants
Money by yearUSD, rounds and grants
2025$5.2M1 record
Largest rounds and grants
$5.2M
Sources: funding announcements, grant and company registers

Money

Fuse Vectors has $5.2M paid in by investors, lenders and donors.

$5.2MPaid in
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
Equity raised · HCVC
Feb 2025 · Pre-seed
$5.2MPaid
Taxes
No public tax figures for this company or its entities.
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

Owners & entities

Sources name HCVC among the owners or investors of Fuse Vectors.

Named investors, no share stated1
Holders and shares as each register or filing states them.

Milestones

Feb 24, 2025
Mar 2023
Each milestone is dated by its source: registers, filings, the press